Process Engineer II

Cambridge Isotope Separations (CIS) has an outstanding opportunity for a Process Engineer II based onsite in our Xenia, OH location. CIS is the world leader in the separation of 13C and 18O and is a subsidiary of Cambridge Isotope Laboratories (CIL) in Massachusetts, the world’s leading producer of stable isotopes and stable isotope-labeled compounds. CIL separates both 13C and 18O at its Xenia, Ohio, facility and has the world’s largest production capacity for both 13C and 18O. CIL also has the only large capacity nongovernmental D2O (Deuterium Oxide) enrichment columns in the world located at its CIS facility.

CIS is looking for a candidate to join the engineering division.  The successful candidate will be reporting to the department head.  Successful candidates are expected to have a chemical engineering degree with knowledge in a variety of chemical processing disciplines and the capability to learn and work in complex systems following hands-on training.  The successful candidate will be expected to work by supporting operations through process engineering and will be involved in some capital projects for the process area.  Candidates should have knowledge of PFD/P&ID, equipment sizing & specifications, material and energy balances.

Responsibilities  

• Coordinating and forecasting maintenance on equipment
• Process design and maintenance of pumping systems, chemical conversion systems, high purity gas system, etc.
• Identifies operational problems and develops operational solution through studying functioning systems, performance results, determining impacts on all impacted systems, and calculating economic impacts
• Investigating customer complaints and implementing improvements

Requirements

• Bachelor of Science degree in Chemical Engineering
• 5- 10 years of experience in a similar role is preferred
• Proven ability to problem solve, troubleshoot and optimize processes
• Strong thermodynamic background
• Ability to make key decisions to keep projects on schedule
• Experience with process control strategies for distillation and reacting processes is beneficial but not required
• Knowledge of a DCS control system integration is beneficial but not required
• MicroSoft Visio or AutoCad experience
• Six Sigma certified preferred or ability to become certified
• Reliable transportation

Benefits

CIL and CIS offer a competitive salary and comprehensive benefits including generous paid time off, Long Term Incentives, 6% matching 401K plan and health insurance with no in-network deductible.

CIL is an EEO/Affirmative Action employer.

Learn more about us on our website: www.isotope.com

About Us:

Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds. With approximately 750 employees and laboratories in four countries, CIL specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (nonradioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. Our chemists substitute common atoms (e.g., 1H, 12C, 14N, 16O) with rare, highly valued isotopes (e.g., 2H or D, 13C, 15N, 18O) so that the final product can be readily measured or traced using mass spectrometry (MS) or nuclear magnetic resonance (NMR). CIL’s products are utilized in laboratories, medical, government and academic research centers and health care facilities worldwide.

We are proud that CIL products have contributed to medical advancements in cancer research, new-drug development, environmental analysis, and medical diagnostic research. In the past decade, as the fields of proteomics and metabolomics have developed as leading techniques for determining biomarkers for disease presence, progression and the monitoring of therapeutic response, CIL has worked closely with industry leaders and researchers to provide the stable isotope-labeled tools needed for improved quantitation and qualification of complex biological systems.

After decades of research, stable isotopes have found their place in an ever expanding commercial scale applications in pharmaceuticals, semiconductors, flat panel displays as well as other high technology fields specifically with deuterium oxide (D2O) and deuterium gases. Pharmaceutical companies have begun to investigate deuteration of molecules that may provide advantages over their existing nondeuterated counterparts. In addition, increasing research into the potential medical advantages of new deuterated drugs is also occurring. In high technology, deuterated organic molecules and deuterium gas are commonly used in the manufacturing of microelectronics and OLEDs, which contribute to the increased lifetime of the devices.

Learn more about us on our website: www.isotope.com